Oncology & Hematology Coding Alert

Question: Can we report two line items of the same code if our physician performs two separate tests to screen for two different strains of flu virus? Can we report multiple units of 87804?

Ohio Subscriber

Answer: Code 87804 (Infectious agent antigen detection by immunoassay with direct optical observation; influenza) describes the rapid flu test approved by the FDA requiring Clinical Laboratory Improvement Act (CLIA)-waived status. You use this code for detection by visual identification.

Reporting tip: Many Medicaid states require you to follow Medicare modifier guidelines and append modifier QW (CLIA-waived test) to 87804. To keep coding uniform, many practices use modifier QW regardless of payer.

Report multiple units: When your office uses an A & B influenza test, you should code multiple units of 87804 when appropriate. For an in-office test that does not identify the influenza strain, report one unit of 87804. For instance, if you perform a test that picks up only the presence of influenza with a single positive/negative, you should report one unit of 87804.

If you use a product that differentiates between influenza A & B and the physician documents both results, you should report 87804 twice. Technically, it is two tests just done in one kit so you are correct in billing it twice, because the physician is documenting two results. If the test does not differentiate between the strains (by just delivering a positive/negative result), then you would bill the code once.

Consider This Alternative for 87804 Denial: You may confront variations in the way payers require you to report multiple units of 87804. Here’s how to decide which method to use:

Best practice: Report two units of 87804 if the payer allows it. Many MACs allow you to report 87804 x 2 without a problem, because the MUEs (medically unlikely edits) that Medicare and some other payers utilize to auto-deny second and subsequent line items limits you to two units of 87804. This means that your carrier will process two units of the code but would most likely auto-deny three or more units billed together.

For payers that do not recognize two units of 87804 and deny the second charge as a duplicate, use modifier 59 (Distinct procedural service) on a second line item of 87804. This modifier indicates that the physician performed a different test for a distinct strain.

Fallback method: In some rare cases (such as with certain state Medicaid providers), you may be advised by your payer to use modifier 91 (Repeat clinical diagnostic laboratory test) on the second listing of 87804. However, before using this coding method, which contradicts current coding guidelines, obtain a written recommendation from the payer.

The May 2009 CPT^® Assistant backs up the advice that modifier 59 is a better option than modifier 91, stating, “Use modifier 59 when separate results are reported for different species or strains that are described by the same CPT^® code. This advice should serve to clarify the use of the modifier in these instances. As a matter of differentiation, modifier 91 is used when, in the course of treating a patient, it is necessary to repeat the same laboratory test on the same day to obtain subsequent test results.”